The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
240 articles
Robbins LLP announced a class action lawsuit against The Chemours Company, alleging overstated demand for Opteon products led to unreliable fiscal 2026 guidance. Following reduced EBITDA guidance, Che
The Law Offices of Frank R. Cruz filed a class action against Chemours alleging misleading statements on Opteon product demand and 2026 guidance, resulting in an 18.63% stock decline.
Goldman Sachs lowered Chemours' price target to $16 from $17, maintaining a Neutral rating based on 2027 earnings estimates. The chemical manufacturer's stock has declined 36% over six months despite
Chemours reported Q2 2026 earnings with adjusted EBITDA exceeding forecasts despite lower net sales in Thermal & Specialized Solutions. The company outlined its 'Pathway to Thrive' strategy and antici
Chemours reported Q2 revenue of $1.591 billion and a $274 million GAAP loss. Analysts show mixed views, with BMO maintaining an $18.00 Buy target while UBS lowered its target to $16.00.
Chemours exceeded responsible procurement targets, with 84% of suppliers improving sustainability performance. The company integrates carbon data into procurement decisions to reduce upstream emission
Chemours shares gained 1.31% to $13.89 despite UBS lowering its price target to $16, while Q2 revenue reached $1.591 billion with a narrowed net loss. Analyst consensus remains Hold with an average 12
Environmental groups accuse Chemours of failing to meet 2019 PFAS discharge reduction targets at its Fayetteville plant, highlighting ongoing pollution concerns despite a $600 million settlement and p
Environmental groups allege Chemours violated a 2019 consent order by failing to adequately reduce PFAS discharges from its Fayetteville Works plant. Chemours disputes these claims despite a recent $6
Chemours and other chemical firms face accusations of evading accountability for global PFAS contamination by shifting production and waste. The report criticizes lax regulations and corporate lobbyin
Chemours Co filed a Form 4 with the U.S. Securities and Exchange Commission on October 2nd, disclosing insider stock transactions. The filing contains standard regulatory data without further operatio
This report provides financial actuals and estimates for Chemours Co. on the Hannover Stock Exchange, covering valuation metrics, analyst forecasts, earnings, and revenue data.
The Village of Bald Head Island secured a $5.7 million settlement from Chemours and partners for PFAS contamination in the Cape Fear River, funding remediation and infrastructure upgrades through 2035
Mizuho maintained its Outperform rating for Chemours but lowered the price target to $18 due to market challenges, noting the stock remains moderately undervalued.
Chemours Co. disclosed cash flow data for 2025 and Q2 2026, recording €224.77 million in operating cash flow for 2025. The report covers historical investing and financing activities listed on the Han
Chemours Co. (2CU) financial data and stock performance are displayed on the Hannover Stock Exchange, including market cap, dividend yield, and analyst ratings.
Options traders are showing significant interest in Chemours stock with high implied volatility, despite a Zacks Sell rating and lowered earnings estimates indicating potential price movement.
Chemours introduces advanced liquid-cooling solutions, including two-phase direct-to-chip and immersion cooling, to enhance energy efficiency and reduce water usage in AI data centers.
Chemours advocates extending the F-Gas transition timeline for mobile air conditioning, citing lack of immediate drop-in replacements for R-1234yf and significant technical challenges.
Chemours allegedly violates a 2019 agreement by discharging PFAS above limits in the Cape Fear River. Following a $590 million settlement, environmental groups urge strict enforcement of emission redu
Chemours supports extending the EU fluorinated gas transition timeline beyond 2040 for mobile air conditioning, citing safety and design challenges with current alternatives like propane and CO₂ compa
Environmental groups allege Chemours violated a 2019 consent order by discharging PFAS into the Cape Fear River, though the company denies the claims and cites mitigation efforts. Legal action may fol
Environmental groups sent a warning letter to Chemours alleging its Fayetteville Works facility violated a 2019 consent order by discharging high PFAS levels without adequate groundwater remediation.
Wood County residents filed a class-action lawsuit against Chemours alleging PFAS contamination from its Washington Works plant damaged homes and land. Plaintiffs seek cleanup, compensation, and medic
Environmental groups accuse Chemours of violating its 2019 consent order on PFAS emissions and cleanup, alleging inadequate handling of ultra-short chain compounds. Despite claiming compliance after $
The Chemours Company Stock Forecasts page appears to be a content stub, displaying only general market indicators like crude oil and currency rates without specific forecast details.
Chemours Co shares rose after reaching a multi-party settlement regarding PFAS emissions at its Fayetteville Works facility. Despite the gain, analysts note the stock remains undervalued while ongoing
North Carolina leaders praise a $590 million settlement between Chemours, DuPont, and Corteva regarding PFAS contamination. However, local well owners remain skeptical about the deal's ability to prov
Chemours faces a new class-action lawsuit from Wood County residents alleging PFAS contamination from its Washington Works landfill caused property damage and health issues. The plaintiffs seek cleanu
Chemours stock held near $14.70 despite a $274 million Q2 loss and ongoing PFAS litigation risks, including a $455 million settlement with North Carolina, while revenue rose to $1.59 billion.
ChemBrief